Rational Optimization of a Peptide-Guided Delivery System Enhances Macrophage Targeting and Drug Biodistribution toward Inflammation

Macrophages play a central role in various inflammatory diseases by regulating immune responses through the secretion of cytokines, chemokines, and growth factors, making them attractive targets for anti-inflammatory therapies. However, macrophage-modulating strategies often face challenges in the delivery specificity toward inflammatory sites, resulting in the unwanted disruption of normal immune functions. We previously identified a macrophage-targeting peptide, termed CRV. Through binding to retinoid X receptor beta (RXRΒ), CRV conjugation may navigate drugs more selectively to the inflammatory sites upon intravenous (IV) injection and thus improve their therapeutic efficacy and safety profile. Here, we optimized this CRV-guided delivery system from multiple aspects. To improve the macrophage targeting, we performed iterative molecular docking-based optimization of CRV sequence. This study identified a variant, termed CRH, with a substantially higher predicted binding affinity to RXRΒ. We further validated that compared to CRV, CRH possesses a greater affinity for RXRΒ protein and macrophage cells in vitro and exhibits a higher accumulation in inflammatory sites after IV injection in vivo. Using dexamethasone (DEX) as an example of anti-inflammatory drugs, we also investigated the impact of other components in this RXRΒ-targeted delivery system on drug biodistribution. Collectively, we report here an optimized, peptide-guided delivery system that may provide a more desirable drug biodistribution profile toward inflammatory sites and thus may serve as the foundation for a more selective delivery of anti-inflammation therapies.

Authors

Institutions

Publication Details

Journal
Molecular Pharmaceutics
Published
2026-11-19
DOI
https://doi.org/10.1021/acs.molpharmaceut.6c01185
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rational Optimization of a Peptide-Guided Delivery System Enhances Macrophage Targeting and Drug Biodistribution toward Inflammation

Xian Wu, Hong‐Bo Pang, Nianwu Wang, Mitchell Kowalke
Molecular Pharmaceutics
Nanoparticle-Based Drug Delivery
article

Rational Optimization of a Peptide-Guided Delivery System Enhances Macrophage Targeting and Drug Biodistribution toward Inflammation

Xian Wu, Hong‐Bo Pang, Nianwu Wang, Mitchell Kowalke
article en

Abstract

Macrophages play a central role in various inflammatory diseases by regulating immune responses through the secretion of cytokines, chemokines, and growth factors, making them attractive targets for anti-inflammatory therapies. However, macrophage-modulating strategies often face challenges in the delivery specificity toward inflammatory sites, resulting in the unwanted disruption of normal immune functions. We previously identified a macrophage-targeting peptide, termed CRV. Through binding to retinoid X receptor beta (RXRΒ), CRV conjugation may navigate drugs more selectively to the inflammatory sites upon intravenous (IV) injection and thus improve their therapeutic efficacy and safety profile. Here, we optimized this CRV-guided delivery system from multiple aspects. To improve the macrophage targeting, we performed iterative molecular docking-based optimization of CRV sequence. This study identified a variant, termed CRH, with a substantially higher predicted binding affinity to RXRΒ. We further validated that compared to CRV, CRH possesses a greater affinity for RXRΒ protein and macrophage cells in vitro and exhibits a higher accumulation in inflammatory sites after IV injection in vivo. Using dexamethasone (DEX) as an example of anti-inflammatory drugs, we also investigated the impact of other components in this RXRΒ-targeted delivery system on drug biodistribution. Collectively, we report here an optimized, peptide-guided delivery system that may provide a more desirable drug biodistribution profile toward inflammatory sites and thus may serve as the foundation for a more selective delivery of anti-inflammation therapies.

Molecular Pharmaceutics
University of Minnesota (US)
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon